Sharps Technology, Inc. (STSS)
2.65
-0.21
(-7.34%)
USD |
NASDAQ |
Dec 10, 16:00
2.64
-0.01
(-0.38%)
After-Hours: 04:45
Sharps Technology Cash from Investing (Quarterly): -187.55M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Acurx Pharmaceuticals, Inc. | 0.00 |
| AIM ImmunoTech, Inc. | 0.296M |
| Perspective Therapeutics, Inc. | 13.99M |
| Protalix Biotherapeutics, Inc. | -0.504M |
| Armata Pharmaceuticals, Inc. | -0.242M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.388M |
| Cash from Financing (Quarterly) | 196.77M |
| Free Cash Flow | -17.00M |
| Free Cash Flow Per Share (Quarterly) | -0.3628 |
| Free Cash Flow to Equity (Quarterly) | -16.46M |
| Free Cash Flow to Firm (Quarterly) | -8.830M |
| Free Cash Flow Yield | -101.0% |